Home NDC 50242-202
EVRYSDI
Product NDC 50242-202
11-digit product format 502420202
Labeler code 50242
Product ID 50242-202_a0597961-b4b9-47ec-961a-919fa9ffba95
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Risdiplam
Dosage form TABLET
Route ORAL
Labeler Genentech, Inc.
Application NDA219285
Marketing category NDA
Marketing start 2025-02-11
Substance RISDIPLAM
Active strength 5 mg/1
Pharmacologic classes Increased Protein Synthesis [PE], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], Survival of Motor Neuron 2 Splicing Modifier [EPC], Survival of Motor Neuron 2 Splicing Modifiers [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base EVRYSDI
Listing expiration 2027-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength RISDIPLAM 5 mg/1
Harmonized Identifiers# Field, Values table Field Values Unii 76RS4S2ET1 Rxcui 2390940, 2390946, 2705365, 2705369
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50242-202-01 EVRYSDI 1 in 1 CARTON TABLET 1 26 50242-202-01 EVRYSDI 30 in 1 BOTTLE, PLASTIC TABLET 30 26
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50242-202 EVRYSDI (RISDIPLAM) POWDER, FOR SOLUTION EVRYSDI (RISDIPLAM) TABLET [GENENTECH, INC.] 20 Current NDC, 2 package rows 20250322_eceb9a99-7191-4be5-87c3-0102707cf98e.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 50242-202-01 50242020201 1 BOTTLE, PLASTIC in 1 CARTON (50242-202-01) / 30 TABLET in 1 BOTTLE, PLASTIC 2025-02-11 No No Historical